Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 200 of 236 results for dementia

  1. Does early review of service provision and referral to additional specialist palliative care services improve outcomes for adults with progressive non-cancer disease thought to be approaching the end of their life?

    with life-limiting neurological disease, such as motor neurone disease or dementia. Such patients are typically referred very late to...

  2. Effectiveness and costs of oral health interventions for care home residents:- How effective and cost effective are oral health interventions in care homes including suitableperson-centred outcome measures?

    differential effects on sub-populations in care homes. This includes: people with dementia, people in poor physical health, those with a...

  3. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    studies demonstrate that up to 15% of people with MND have frontotemporal dementia. A further third of people with MND have changes in...

  4. Environmental adaptations aimed at reducing the risk of falling in older inpatients:- What environmental adaptations can be made in existing inpatient units, and should be considered when inpatient units are built, to reduce the risk of falls and injuries in older inpatients?

    Any explanatory notes(if applicable) Why this is important:- Dementia, delirium, poor mobility and balance, urgent or frequent toilet...

  5. Interventions for preventing falls in older inpatients:- How can falls among older inpatients be prevented? Which patients are most likely to benefit from falls prevention interventions, and does the effectiveness of interventions relate to the patient's length of stay?

    nor has their effectiveness in specific subgroups such as patients with dementia. High-quality randomised controlled trials conducted in...

  6. Developing a medications policy and procedures for use in social care

    in Suffolk at 17.9% compared to 16.7% in the East of England region and dementia prevalence is also 0.1% high. How did you implement the...

  7. Pharmacist Led Hypertension Review Project in Black (African or African-Caribbean origin) Patients

    prevalence of hypertension and subsequent CVD, stroke, renal failure and dementia and therefore the potential risks associated with...

  8. Telecare:- What types of telecare are most effective and cost effective, when provided to older people as part of a package of home care?

    acceptability and accessibility (particularly for people with complex needs such as dementia). Cost information from a societal...

  9. Impact of multi-disciplinary involvement to improve smoking cessation in the acute admissions unit (AMU)

    we sought where necessary. Challenges with mental health patients e.g. dementia and consent – individual best interest approach The...

  10. Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?

    an increased risk of osteoporosis, cardiovascular disease and possibly dementia. There is uncertainty about the diagnosis, time course...

  11. Hearing loss prevalence in people who under-present for hearing loss:- What is the prevalence of hearing loss among populations who under-present for possible hearingloss?

    report their difficulties. These include people with learning disabilities, dementia and mild cognitive impairment.Given the importance...

  12. Diagnostics advisory committee members

    from 2015 to 2020 for his doctoral research, 'Approaches to diagnosing dementia syndrome in general practice'. He continues to focus on...

  13. Knowsley Healthy Homes Initiative

    The Healthy Homes initiative is led by Knowsley Council's public health team in partnership with a number of local agencies.

  14. Oral health: local authorities and partners (PH55)

    This guideline covers improving oral health by developing and implementing a strategy that meets the needs of people in the local community. It aims to promote and protect people’s oral health by improving their diet and oral hygiene, and by encouraging them to visit the dentist regularly.

  15. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

  16. Lumbar infusion test for the investigation of normal pressure hydrocephalus (IPG263)

    Evidence-based recommendations on the lumbar infusion test for the investigation of normal pressure hydrocephalus. This involves inserting a lumbar needle into the spinal sac, recording the pressure of the CSF as fluid is infused into the sac.

  17. Excess winter deaths and illness and the health risks associated with cold homes (NG6)

    This guideline covers reducing the health risks (including preventable deaths) associated with living in a cold home. It aims to improve the health and wellbeing of people vulnerable to the cold. Improving the temperature in homes, by improving energy efficiency, may also help reduce unnecessary fuel consumption.

  18. Decision-making and mental capacity (NG108)

    This guideline covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so. It also helps practitioners to keep people who lack capacity at the centre of the decision-making process.

  19. LQD Spray for treating acute and chronic wounds (MIB202)

    NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .

  20. Motor neurone disease (QS126)

    This quality standard covers assessing and managing motor neurone disease, including care, support and planning after diagnosis. It describes high-quality care in priority areas for improvement.

  21. Screening secondary care patients for atrial fibrillation: The SOS-AF service

    median total healthcare costs due to their greater burden of disability, dementia and death. As highlighted in NICE guidelines,...

  22. Neighbourhood Integrated Medicines Optimisation Team: Improving medicines use at home

    Hospital and 141 from other healthcare professionals such as district nurses, dementia re-ablement services and social services. We also...

  23. STOP LOOK CARE

    Dementia, disability and frailty in later life – mid-life approaches to delay or

  24. The Oral Health Needs of Older People Living in Islington Nursing Homes.

    considering that this population is also burdened by co-morbidities and dementia in particular, this poses challenges for cooperation to...

  25. Improving Medicines Optimisation for Care Home Residents and Providing Medicines Management Support to Care Homes - The Wigan Borough CCG Approach

    Wigan Borough CCG has employed a team of pharmacists and pharmacy technicians to work with GP practices, residential and nursing homes to carry out structured medication reviews for care homes

  26. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

  27. Research recommendations

    tools: for people with pre-existing cognitive impairment, for example dementia, learning disability or severe depression for people who...

  28. Dementia: supporting people with dementia and their carers in health and social care (CG42)

    This guidance has been updated and replaced by NICE guideline NG97.

  29. Safe staffing for nursing in adult inpatient wards in acute hospitals (SG1)

    This guideline covers organisational and managerial approaches to safe nurse staffing of inpatient wards for people aged 18 and over in acute hospitals. It aims to ensure that patients receive the nursing care they need, regardless of the ward to which they are allocated, the time of the day, or the day of the week.

  30. HIV testing: encouraging uptake (QS157)

    This quality standard covers interventions to improve the uptake of HIV testing among people who may have undiagnosed HIV. It focuses on increasing testing to reduce undiagnosed infection in people at increased risk of exposure. It describes high-quality care in priority areas for improvement.

  31. Dementia: independence and wellbeing (QS30)

    This quality standard has been updated and replaced by NICE quality standard 184

  32. “Get up, Get Dressed” - Frailty Care on a Surgical Ward

    prevention of deconditioning. This includes providing information about dementia care, recognising nutrition and hydration needs, as...

  33. Insertion of a magnetic bead band for faecal incontinence (IPG483)

    Evidence-based recommendations on insertion of a magnetic-bead band for faecal incontinence. This involves placing a ring of magnetic beads into a tunnel made around the anus to prevent incontinence.

  34. What training, support or interventions help to reduce caring-related accidents or incidents?

    evidence suggested that START was cost effective for carers of people with dementia and the committee agreed that it was reasonable to...

  35. Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block (TA324)

    Evidence-based recommendations on dual-chamber pacemakers for treating symptomatic bradycardia caused by sick sinus syndrome without atrioventricular block.

  36. Oldham Exercise Falls Prevention Service

    them. The instructor's complete additional training for sight impairment, dementia, cerebral vascular accident and Parkinson's disease....

  37. Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis (TA590)

    Evidence-based recommendations on fluocinolone acetonide intravitreal implant (Iluvien) for treating recurrent non-infectious uveitis in adults.

  38. Bisphosphonates for treating osteoporosis (TA464)

    Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis.

  39. Schizophrenia: lurasidone (ESNM48)

    Summary of the evidence on lurasidone (Latuda) for schizophrenia in adults aged 18 and over to inform local NHS planning and decision-making

  40. Dementia: support in health and social care (QS1)

    This quality standard has been updated and replaced by NICE quality standard 184

  41. Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32)

    This guideline covers identifying and caring for adults who are malnourished or at risk of malnutrition in hospital or in their own home or a care home. It offers advice on how oral, enteral tube feeding and parenteral nutrition support should be started, administered and stopped. It aims to support healthcare professionals identify malnourished people and help them to choose the most appropriate form of support.

  42. InterDry for intertrigo (MIB192)

    NICE has developed a medtech innovation briefing (MIB) on InterDry for intertrigo .

  43. People's experience in adult social care services: improving the experience of care and support for people using adult social care services (NG86)

    This guideline covers the care and support of adults receiving social care in their own homes, residential care and community settings. It aims to help people understand what care they can expect and to improve their experience by supporting them to make decisions about their care.

  44. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)

    Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.

  45. QTUG for assessing falls risk and frailty (MIB73)

    NICE has developed a medtech innovation briefing (MIB) on the Quantitative Timed Up and Go (QTUG)

  46. Management of aggression, agitation and behavioural disturbances in dementia: carbamazepine (ESUOM40)

    This evidence summary has been updated and replaced by NICE guideline NG97.

  47. Rehabilitation after traumatic injury (NG211)

    This guideline covers complex rehabilitation needs after traumatic injury, including assessment and goal setting, rehabilitation plans and programmes, physical, psychological and cognitive rehabilitation, rehabilitation for specific injuries, coordination of rehabilitation in hospital, at discharge and in the community, and commissioning and organising rehabilitation services.

  48. Supporting adult carers (NG150)

    This guideline covers support for adults (aged 18 and over) who provide unpaid care for anyone aged 16 or over with health or social care needs. It aims to improve the lives of carers by helping health and social care practitioners identify people who are caring for someone and give them the right information and support. It covers carers’ assessments, practical, emotional and social support and training, and support for carers providing end of life care.